Characterization and in vitro properties of potential probiotic Bifidobacterium strains isolated from breast-fed infant feces

Annals of Microbiology

Volumn 66, Issue 3, 2016, Pages 1027-1037

  Zuo, Fanglei ^a,b   Yu, Rui ^a,b   Feng, Xiujuan ^a   Chen, Lili ^a,b   Zeng, Zhu ^a,b   Khaskheli, Gul Bahar ^a,b   Ma, Huiqin ^a   Chen, Shangwu ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Beijing Engineering Research Center of Function Agricultural Microbiology   (China)

Author keywords

Adhesion; Aggregation; Bifidobacterium; Infant feces; Probiotics

Indexed keywords

EID: 84952029595     PISSN: 15904261     EISSN: 18692044     Source Type: Journal    
DOI: 10.1007/s13213-015-1187-x     Document Type: Article

References (80)

1. Ammor MS, Flórez AB, Van Hoek AHAM, de los Reyes-Gavilán CG, Aarts HJM, Margolles A, Mayo B (2008) Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria. J Mol Microb Biotech 14:6–15
2. Andriantsoanirina V, Allano S, Butel MJ, Aires J (2013) Tolerance of Bifidobacterium human isolates to bile, acid and oxygen. Anaerobe 21:39–42
3. Arboleya S, Ruas-Madiedo P, Margolles A, Solís G, Salminen S, de los Reyes-Gavilán CG, Gueimonde M (2011) Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk. Int J Food Microbol 149:28–36
4. Beerens H (1990) An elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 11:155–175
5. Braegger C et al (2011) Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenter Nutr 52:238–250
6. Blanchard E, Zhu P, Schuck P (2013) Infant formula powders. In: Bhandari B, Bansal N, Zhang M, Schuck P (eds) Handbook of food powders: Processes and properties. Vol. no. 255. Woodhead Publishing, Cambridge, UK, pp 465–480
7. Candela M, Perna F, Carnevali P, Vitali B, Ciati R, Gionchetti P, Rizzello F, Campieri M, Brigidi P (2008) Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol 125:286–292
8. Canzi E, Guglielmetti S, Mora D, Tamagnini I, Parini C (2005) Conditions affecting cell surface properties of human intestinal bifidobacteria. Anton Leeuw Int J G 88:207–219
9. Cheikhyoussef A, Pogori N, Chen HQ, Tian FW, Chen W, Tang J, Zhang H (2009) Antimicrobial activity and partial characterization of bacteriocin-like inhibitory substances (BLIS) produced by Bifidobacterium infantis BCRC 14602. Food Control 20:553–559
10. Collado MC, Hernández M, Sanz Y (2005) Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains. J Food Protect 68:1034–1040
11. Del Re B, Sgorbati B, Miglioli M, Palenzona D (2000) Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett Appl Microbiol 31:438–442
12. EFSA (2008) Technical guidance prepared by the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) on the update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J. 732, 1e15 (output obsolete)
13. EFSA (2012) Scientific opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed. EFSA J 10:3020. doi:10.2903/j.efsa.2011.2497
14. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, Motherway MO, Shanahan F, Nally K, van Sinderen D, Dougan G (2012) Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A 109:2108–2113
15. FAO/WHO (2006) Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition paper 85. ISBN: 92-5-105513-0
16. Ferraris L, Aires J, Waligora-Dupriet AJ, Butel MJ (2010) New selective medium for selection of bifidobacteria from human feces. Anaerobe 16:469–471
17. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543–547
18. García-Cayuela T, Korany AM, Bustos I, Gómez de Cadiñanos LP, Requena T, Peláez C, Martínez-Cuesta MC (2014) Adhesion abilities of dairy Lactobacillus plamtarum strains showing an aggregation phenotype. Food Res Int 57:44–50
19. Garrigues C, Johansen E, Pedersen MB (2010) Complete genome sequence of Bifidobacterium animalis subsp. lactis BB-12, a wildly consumed probiotic strain. J Bacteriol 192:2467–2468
20. Goh YJ, Klaenhammer TR (2010) Functional roles of aggregation-promoting factor in stress tolerance and adherence of Lactobacillus acidophilus NCFM. Appl Environ Microbiol 76:5005–5012
21. Gonzalez-Rodriguez I, Sanchez B, Ruiz L, Turroni F, Ventura M, Ruas-Madiedo P, Gueimonde M, Margolles A (2012) Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Appl Environ Microbiol 78:3992–3998
22. Guglielmetti S, Tamagnini I, Minuzzo M, Arioli S, Parini C, Comelli E, Mora D (2009) Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines. Curr Microbiol 59:167–172
23. Hansen LT, Allan-Wojtas PM, Jin Y-L, Paulson AT (2004) Survival of Ca-alginate microencapsulated Bifidobacterium spp. in milk and simulated gastrointestinal conditions. Food Microbiol 19:35–45
24. Hao YL, Huang DW, Guo HY, Xiao M, An HR, Zhao L, Zuo FL, Zhang B, Hu SN, Song SH, Chen SW, Ren FZ (2011) Complete genome sequence of Bifidobacterium longum subsp. longum BBMN68, a new strain from a healthy Chinese centenarian. J Bacteriol 193:787–788
25. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenter Nutr 30:61–67
26. Hartemink R, Kok BJ, Weenk GH, Rombouts FM (1996) Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. J Microbiol Meth 27:33–43
27. He F, Ouwehand AC, Hashimoto H, Isolauri E, Benno Y, Salminen S (2001) Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol Immunol 45:259–262
28. Jones BV, Begley M, Hill C, Gahan CGM, Marchesi JR (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 105:13580–13585
29. Kankainen M, Paulin L, Tynkkynen S, Ossowski I, Reunanen J, Partanen P, Satokari R, Vesterlund S, Hendrickx APA, Lebeer S, De Keersmaecker SCJ, Vanderleyden J, Hämäläinen T, Laukkanen S, Salovuori N, Ritari J, Alatalo E, Korpela R, Mattila-Sandholm T, Lassig A, Hatakka K, Kinnunen KT, Karjalainen H, Saxelin M, Laakso K, Surakka A, Palva A, Salusjärvi T, Auvinen P, de Vos WM (2009) Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 106:17193–17198
30. Kim BJ, Kim HY, Yun YJ, Kim BJ, Kook YH (2010) Differentiation of Bifidobacterium species using partial RNA polymerase β-subunit (rpoB) gene sequences. Int J Syst Evol Micr 60:2697–2704
31. Kiwaki M, Sato T (2009) Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int J Food Microbiol 134:211–215
32. Klein G, Hallmann C, Casas IA, Abad J, Louwers J, Reuter G (2000) Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J Appl Microbiol 89:815–824
33. Kolida S, Saulnier DM, Gibson GR (2006) Gastrointestinal microflora: probiotics. Adv Appl Microbiol 59:187–219
34. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling GW (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-dpecific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61:3069–3075
35. Liu WJ, Chen YF, Kwok LY, Li MH, Sun T, Sun CL, Wang XN, Dan T, Menghebilige ZHP, Sun TS (2013) Preliminary selection for potential probiotic Bifidobacterium isolated from subjects of different Chinese ethnic groups and evalution of their fermentation and storage characteristics in bovine milk. J Dairy Sci 96:6807–6817
36. Makras L, De Vuyst L (2006) The in vitro inhibition of Gram-negative pathogenic bacteria by bifidobacteria is caused by the production of organic acids. Int Dairy J 16:1049–1057
37. Martinz FAC, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP (2013) Bacteriocin production by Bifidobacterium spp.: A review. Biotechnol Adv 13:482–488
38. Mayrhofer S, Mair C, Kneifel W, Domig KJ (2011) Susceptibility of bifidobacteria of animal origin to selected antimicrobial agents. Chemot Res Practi 989520
39. Meile L, Le Blay G, Thierry A (2008) Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium. Int J Food Microbiol 126:316–320
40. Meyrand M, Guillot A, Goin M, Furlan S, Armalyte J, Kulakauskas S, Cortes-Perez NG, Thomas G, Chat S, Péchoux C, Dupres V, Hols P, Dufrêne YF, Trugnan G, Chapot-Chartier M-P (2013) Surface proteome analysis of a natural isolate of Lactococcus lactis reveals the presence of pili able to bind human intestinal epithelial cells. Mol Cell Proteomics 12:3935–3947
41. Midtvedt A-C, Midtvedt T (1992) Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life. J Pediatr Gastr Nutr 15:395–403
42. TM Aerobic Count plates. Food Microbiol 39:96–102
43. Motherway MOC, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, O'Brien F, Flynn K, Casey PG, Munoz JAM, Kearney B, Houston AM, O'Mahony C, Higgins DG, Shanahan F, Palva A, de Vos WM, Fitzgerald GF, Ventura M, O'Toole PW, van Sinderen D (2011) Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved hostcolonization factor. Proc Natl Acad Sci U S A 108:11217–11222
44. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft H-JF, Doré J, Blaut M (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027–1033
45. Muñoa FJ, Pares R (1988) Selective medium for isolation and enumeration of Bifidobacterium spp. Appl Environ Microbiol 54:1715–1718
46. Muňoz-Quezada S, Chenoll E, Vieites JM, Bermúdez-Brito SM, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F, Suárez A, Ramón D, Gil A (2013) Isolation, identification and characterisation of three novel probiotic strains (Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) from the faeces of exclusively breast-fed infants. Brit J Nutr 109:S51–S62
47. Nagaoka S, Hojo K, Murate S, Mori T, Ohshima T, Maeda N (2007) Interactions between salivary Bifidobacterium adolescentis and other oral bacteria: in vitro coaggregation and coadhesion assays. FEMS Microbiol Lett 281:183–189
48. Noriega L, Gueimonde M, Sánchez B, Margolles A, de los Reyes-Gavilán CG (2004) Effect of the adaptation to high bile salts concentration on glycosidic activity, survival at low pH and cross-resistance to bile salts in Bifidobacterium. Int J Food Microbiol 94:79–86
49. Ouwehand AC, Salminen S (1998) The health effects of cultured milk products with viable and non viable bacteria. Int Dairy J 8:749–758
50. Ouwehand AC, Salminen S, Isolauri E (2002) Probiotics: an overview of beneficial effects. Anton Leeuw Int J G 82:279–289
51. Pablo FP, Yessica M, Disalvo EA, De Antoni GL (1998) Surface properties of bifidobacterial strains of human origin. Appl Environ Microbiol 64:21–26
52. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. Plos Biol 5:1556–1573
53. Pan WH, Li PL, Liu ZY (2006) The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians’ faeces. Anaerobe 12:148–152
54. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511–21
55. Pereira DIA, Gibson GR (2002) Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 68:4689–4693
56. Picot A, Lacroix C (2004) Encapsulation of bifidobacteria in whey protein-based microcapsules and survival in simulated gastrointestinal conditions and in yoghurt. Int Dairy J 14:505–515
57. Prasanna PHP, Grandison AS, Charalampopoulos D (2014) Bifidobacteria in milk products: an overview of physiological and biochemical properties, exopolysaccharide production, selection criteria of milk products and health benefits. Food Res Int 55:247–262
58. Raeisi SN, Ouoba LII, Farahmand N, Sutherland J, Ghoddusi HB (2013) Variation, viability and validity of bifidobacteria in fermented milk products. Food Con 34:691–697
59. Rahman MM, Kim WS, Kumura H, Shimazaki KI (2008) Autoaggregation and surface hydrophobicity of bifidobacteria. World J Microbiol Biotechnol 24:1593–1598
60. Requena T, Burton J, Matsuki T, Munro K, Simon MC, Tanaka R, Watanabe K, Tannock GW (2002) Identification, detection, and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Appl Environ Microbiol 68:2420–2427
61. Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL (2010) Examination of faecal Bifidobacteterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156:3329–3341
62. Russell DA, Ross RP, Fitzgerald GF, Stanton C (2011) Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 149:88–105
63. Saarela M, Mogensen G, Fondėn R, Mättö J, Mattila-Sandholm T (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84:197–215
64. Saavedra JM, Bauman NA, Perman JA, Yolken RH, Oung I (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. The Lancet 344:1046–1049
65. Sánchez B, Champomier-Vergés MC, Collado MC, Anglade P, Baraige F, Sanz Y, de los Reyes-Gavilán CG, Margolles A, Zagorec M (2007) Low-pH adaptation and the acid tolerance response of Bifidobacterium longum biotype longum. Appl Environ Microbiol 73:6450–6459
66. Sánchez B, Ruiz L, de los Reyes-Gavilan CG, Margolles A (2008) Proteomics of stress response in Bifidobacterium. Front Biosci 13:6905–6919
67. Sánchez B, Ruiz L, Gueimonde M, Ruas-Madiedo P, Margolles A (2013) Adaptation of bifidobacteria to the gastrointestinal tract and functional consequences. Pharmacol Res 69:127–136
68. Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach JT, Hörmannsperger G, Huys G (2010) Safety assessment of probiotics for human use. Gut Microbes 1:164–185
69. Sato T, Iino T (2009) Genetic analyses of the antibiotic resistance of Bifidobacterium bifidum strain Yakult YIT 4007. Int J Food Microbiol 137:254–258
70. Scheller M, O’Sullivan DJ (2011) Comparative analysis of an intestinal strain of Bifidobacterium longum and a strain of Bifidobacterium animalis subspecies lactis in chrddar cheese. J Dairy Sci 94:1122–1131
71. Sharma P, Tomar SK, Goswami P, Sangwan V, Singh R (2014) Antibiotic resistance among commercially available probiotics. Food Res Int 57:176–195
72. Silvi S, Rumney CJ, Rowland IR (1996) An assessment of three selective media for bifidobacteria in faeces. J Appl Bacteriol 81:561–564
73. Simpson PJ, Stanton C, Fitzgerald GF, Ross RP (2005) Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage. J Appl Microbiol 99:493–501
74. Tang L, Lee AH, Binns CW, Yang YX, Wu Y, Li YX, Qiu LQ (2014) Widespread usage of infant formula in China: a major public health problem. Birth 41:339–343
75. Touré R, Kheadr E, Lacroix C, Moroni O, Fliss I (2003) Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J Appl Microbiol 95:1058–1069
76. Tuo YF, Yu YL, Ai LZ, Wu ZG, Guo BH, Chen W (2013) Aggregation and adhesion properties of 22 Lactobacillus strains. J Dairy Sci 96:4252–4257
77. Turroni F, Serafini F, Foroni E, Duranti S, Motherway MO, Taverniti V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sánchez B, Santoni A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza P, Bolchi A, Cuglielmetti S, van Sinderen D, Ventura M (2013) Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc Natl Acad Sci U S A 110:11151–11156
78. Wei YX, Zhang ZY, Liu C, Malakar PK, Guo XK (2012) Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences. World J Gastroentero 18:479–488
79. Zhou JS, Pillidge CJ, Gopal PK, Gill HS (2005) Antibiotic susceptibility profiles of new probiotic Lactobacillus ans Bifidobacterium strains. Int J Food Microbiol 98:211–217
80. Zuo FL, Feng XJ, Sun XF, Du C, Chen SW (2013) Characterization of plasmid pML21 of Enterococcus faecalis ML21 from koumiss. Curr Microbiol 66:103–105